MS

Satellos Bioscience Inc. Common Stock

MSLE · Nasdaq

Satellos Bioscience Inc. Common Stock (MSLE) is a Medical pharmaceuticals company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Satellos Bioscience Inc. Common Stock in 2026. The next earnings report is expected on August 31, 2026.

Scheduled earnings dates

31 Aug 2026 25 Nov 2026

Earnings calendar

Next earnings date

31 Aug 2026

In 11 days

EPS estimate

-0.51

Revenue estimate

0

Past earnings

13 Aug 2026
EPS actual
-0.55 (-7.2%)
estimate -0.51
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
02 Jun 2026
EPS actual
—
estimate -0.49
Revenue actual
—
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
15 May 2026
EPS actual
-0.52 (-8.0%)
estimate -0.49
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
27 Mar 2026
EPS actual
-0.51 (-34.2%)
estimate -0.38
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
14 Nov 2025
EPS actual
-0.36 (-11.1%)
estimate -0.33
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

Satellos Bioscience Inc. Common Stock missed consensus estimates in its latest earnings report, with EPS of $-0.5472 versus an estimate of $-0.5103 and revenue of $0 meeting estimates. In the prior quarter, EPS also missed estimates while revenue met expectations.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki on July 27, 2012 and is headquartered in Toronto, Canada.

Sector
Healthcare
Industry
Medical pharmaceuticals
Country
Canada
Exchange
Nasdaq
CEO
Francis Gleeson
Employees
14
IPO date
10 May 2024
ISIN
CA80401L8033
Website
satellos.com

Frequently asked questions

When does Satellos Bioscience Inc. Common Stock (MSLE) next report earnings?

Satellos Bioscience Inc. Common Stock (MSLE) is scheduled to report earnings on August 31, 2026.

What was Satellos Bioscience Inc. Common Stock's most recent earnings date?

Satellos Bioscience Inc. Common Stock (MSLE) last reported earnings on August 13, 2026.

Where is Satellos Bioscience Inc. Common Stock stock listed?

Satellos Bioscience Inc. Common Stock (MSLE) is listed on Nasdaq.